![Illustrative: Cell culture for the biomedical diagnostics. Deposit Photos](https://nocamels.com/wp-content/uploads/2018/12/stemcellsuspension-350x233.jpg)
BrainStorm Gets FDA Approval For New Experimental Drug To Treat Progressive MS
The Israeli-American biotechnology company is also currently conducting a Phase III clinical trial for the treatment of amyotrophic lateral sclerosis (ALS).
December 18, 2018